Evidence map›Paper›PMID 40411507›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2025

Chronic treatment with adenosine A1 receptor antagonist promotes neurogenesis and improves outcome after cerebral ischemia.

Maria Ardaya, Monica Benito-Muñoz, Esther Rubio-López, Maider Garbizu, Laura Aguado, Naroa Mocha-Muñoz, Leyre Iglesias, Unai Alduntzin, Carlos Matute, Federico N Soria and 5 more

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria ArdayaDonostia International Physics Center (DIPC), San Sebastian, Spain.ORCID 0000-0002-0103-5649
Monica Benito-MuñozAchucarro Basque Center for Neuroscience, Leioa, Spain.
Esther Rubio-LópezAchucarro Basque Center for Neuroscience, Leioa, Spain.
Maider GarbizuAchucarro Basque Center for Neuroscience, Leioa, Spain.
Laura AguadoAchucarro Basque Center for Neuroscience, Leioa, Spain.
Naroa Mocha-MuñozAchucarro Basque Center for Neuroscience, Leioa, Spain.
Leyre IglesiasAchucarro Basque Center for Neuroscience, Leioa, Spain.
Unai AlduntzinDonostia International Physics Center (DIPC), San Sebastian, Spain.
Carlos MatuteAchucarro Basque Center for Neuroscience, Leioa, Spain.ORCID 0000-0001-8672-711X
Federico N SoriaAchucarro Basque Center for Neuroscience, Leioa, Spain.
Vanessa Gómez-VallejoCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), San Sebastian, Spain.
Aitzol García-EtxarriDonostia International Physics Center (DIPC), San Sebastian, Spain.
Jordi LlopCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), San Sebastian, Spain.
Fabio CavaliereAchucarro Basque Center for Neuroscience, Leioa, Spain.
Abraham MartínAchucarro Basque Center for Neuroscience, Leioa, Spain.ORCID 0000-0002-5357-4935

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine A1 receptors (A1ARs) are promising targets for stroke treatment, potentially due to their relatively unexplored effects on proliferation and differentiation of newborn neurons. In this study, we investigated the impact of chronic treatment with the A1ARs antagonist DPCPX on neurogenesis following MCAO in rodents, using PET with [

Indexed as

Adenosine A1 Receptor AntagonistsBrain IschemiaNeurogenesisXanthinesAnimalsCell ProliferationMaleMiceMice, Inbred C57BLPositron-Emission TomographyRatsRats, Sprague-DawleyReceptor, Adenosine A11,3-dipropyl-8-cyclopentylxanthineAdenosine A1 Receptor AntagonistsReceptor, Adenosine A1Xanthines[18F]FLTA1ARsbrain ischemiaDPCPXneurogenesisPET imaging

Identifiers

PMID40411507
PMCPMC12103464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.